awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36437458-52546E9F-68E0-4C8E-9688-9E9FF8506262
Q36437458-52546E9F-68E0-4C8E-9688-9E9FF8506262
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36437458-52546E9F-68E0-4C8E-9688-9E9FF8506262
Meta-analysis of the efficacy and safety of adding an angiotensin receptor blocker (ARB) to a calcium channel blocker (CCB) following ineffective CCB monotherapy.
P2860
Q36437458-52546E9F-68E0-4C8E-9688-9E9FF8506262
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36437458-52546E9F-68E0-4C8E-9688-9E9FF8506262
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f3bc3f39d511c7b747f8414cb72cf1af32e4b8ba
P2860
Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders.